A prospective exploratory study on the safety of gastric endoscopic submucosal dissection without cessation of warfarin.
Phase 2
- Conditions
- The lesion that is indicated in gastric endoscopic submucosal dissection in patients who use warfarin for prevention of thrombosis.
- Registration Number
- JPRN-UMIN000020850
- Lead Sponsor
- The University of Tokyo Hospital Department of Gastroenterology, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Women who has a possibility of pregnancy or is during pregnancy (2)Women who has baby and is nursing (3)Patients who undergo hemodialysis (4)To assess the general condition and complications of patients, if the attending physician has determined that it is difficult to entry.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The bleeding rate after gastric endoscopic submucosal dissection from immediately until the 28th day
- Secondary Outcome Measures
Name Time Method 1.The existence of bleeding requiring hemostatic procedure in second-look gastrointestinal endoscopy (day1). 2.Early bleeding rate after gastric endoscopic submucosal dissection (from immediately after gastric endoscopic submucosal dissection to before the day2 meal starts). 3.Delayed bleeding rate after gastric endoscopic submucosal dissection (after the day2 meal started). 4.Duration of hospitalization.